Sign In
Buy VERU
$2.25
-0.100 (-4.26%)
At Close: Jun 03, 2026
Top 5 Defensive Stocks That Are Set To Fly
07:37am, Friday, 24'th Mar 2023
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
Veru to Present at the Oppenheimer 33rd Annual Healthcare Conference
08:30am, Tuesday, 07'th Mar 2023
MIAMI, FL., March 07, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for on
Why Is Veru (VERU) Stock Down 37% Today?
09:23am, Friday, 03'rd Mar 2023
Veru (NASDAQ: VERU ) stock is taking a beating on Friday after the FDA denied the company's request for EUA for its Covid-19 treatment. That rejection has to do with sabizabulin, which is Veru's drug
Veru stock plummets toward 2 1/2-year low after FDA denies EUA request for COVID-19 treatment
07:00am, Friday, 03'rd Mar 2023
Share of Veru Inc. VERU, +0.53% plunged 31.0% toward a 2 1/2-year low in premarket Friday, after the U.S. Food and Drug Administration turned down the biopharmaceutical company's request for Emergency
Veru Inc.: Q1 Revenues Fall Short And Uncertainty Looms, Making It Risky
01:33pm, Monday, 27'th Feb 2023
Veru Inc. is eyeing emergency use authorization for its COVID-19 drug Sabizabulin, which is currently under FDA review. Veru Inc. shares fell around 20% to a 52-week low after reporting Q1 FY23 result
Veru Inc. (VERU) Q1 2023 Earnings Call Transcript
02:37pm, Thursday, 09'th Feb 2023
Veru Inc. (NASDAQ:VERU ) Q1 2023 Earnings Conference Call February 9, 2023 8:00 AM ET Company Participants Sam Fisch - Executive Director, Investor Relations & Corporate Communications Mitchell Steine
Veru Inc. (VERU) Reports Q1 Loss, Misses Revenue Estimates
09:02am, Thursday, 09'th Feb 2023
Veru Inc. (VERU) delivered earnings and revenue surprises of -21.05% and 50.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Veru to Report Fiscal 2023 First Quarter Financial Results on February 9, 2023
08:30am, Thursday, 26'th Jan 2023
MIAMI, FL, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for onco
Why Is VERU Stock Up 8% Today?
03:20pm, Tuesday, 10'th Jan 2023
One of last year's surprise hits in the biotech sphere, Veru (NASDAQ: VERU ) is making headlines once again today. Currently, VERU stock is up 8%.
Jim Cramer Calls This Small-Cap Energy Stock The 'Best Natural Gas Company And A Great Oil Company'
01:32pm, Monday, 09'th Jan 2023 Benzinga
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Corning Incorporated (NYSE: GLW) is "fine."
When asked about Axon Enterprise Inc (NASDAQ: AXON), he said, "It’s a terrific law enforcemen
If You Invested $1,000 in Veru in 2020, This Is How Much You Would Have Today
10:57am, Thursday, 29'th Dec 2022 The Motley Fool
Despite the recent sell-off, you'd still have a solid profit on Veru if you bought the stock nearly three years ago.
These Were the 5 Best and Worst Performing Small-Cap Stocks in November 2022
10:55pm, Tuesday, 13'th Dec 2022
Investing in small-cap stocks is usually a very risky business, but they could offer quick and hefty returns.
Is There any Hope for Veru Stock?
02:45pm, Saturday, 10'th Dec 2022 The Motley Fool
The near term looks bad, and it might take a while to get better.
Is There any Hope for Veru Stock?
09:45am, Saturday, 10'th Dec 2022
The near term looks bad, and it might take a while to get better.
Veru Inc. (VERU) Reports Q4 Loss, Lags Revenue Estimates
12:45pm, Monday, 05'th Dec 2022 Zacks Investment Research
Veru Inc. (VERU) delivered earnings and revenue surprises of -75.86% and 77.51%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
